Literature DB >> 6110456

Central cardiovascular effects of narcotic analgesics and enkephalins in rats.

M Bellet, J L Elghozi, P Meyer, M G Pernollet, H Schmitt.   

Abstract

1. The cardiovascular effects of morphine, fentanyl, [D-Ala2]-met-enkephalinamide were analyzed after intracisternal injection in anaesthetized rats. PaO2 was measured as an index of respiratory function. 2. At low doses in spontaneously breathing rats, morphine, fentanyl and [D-Ala2]-met-enkephalinamide induced a pressor response with slight tachycardia and no significant change in PaO2. 3. The pressor response appeared to be due to activation of opiate receptors and mediated through the sympathetic nervous system. 4. High doses of morphine and [D-Ala2]-met-enkephalinamide induced a biphasic effect with a secondary hypotension associated with bradycardia in spontaneously breathing rats. A marked reduction in PaO2 was found during the depressor phase. 5. High doses of [D-Ala2]-met-enkephalinamide produced only a pressor response in artificially-ventilated rats with no signs of secondary hypotension. 6. Our data support the idea that morphinomimetic agents are centrally pressor at low doses in the rat. The respiratory depression observed with high doses may be the cause of hypotension.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6110456      PMCID: PMC2044458          DOI: 10.1111/j.1476-5381.1980.tb10949.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  An analog of enkephalin having prolonged opiate-like effects in vivo.

Authors:  J M Walker; G G Berntson; C A Sandman; D H Coy; A V Schally; A J Kastin
Journal:  Science       Date:  1977-04-01       Impact factor: 47.728

2.  Noradrenaline: central inhibitory control of blood pressure and heart rate.

Authors:  W De Jong
Journal:  Eur J Pharmacol       Date:  1974-11       Impact factor: 4.432

3.  Porcine pituitary peptides with opiate-like activity: partial purification and effects in the rat after intraventricular injection.

Authors:  H Teschemacher; J Bläsig; W Kromer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-09       Impact factor: 3.000

4.  Morphine and beta-endorphin inhibit release of noradrenaline from cerebral cortex but not of dopamine from rat striatum.

Authors:  S Arbilla; S Z Langer
Journal:  Nature       Date:  1978-02-09       Impact factor: 49.962

5.  Cardiovascular effects of morphine and opioid peptides following intracisternal administration in chloralose-anesthetized rats.

Authors:  P Bolme; K Fuxe; L F Agnati; R Bradley; J Smythies
Journal:  Eur J Pharmacol       Date:  1978-04-01       Impact factor: 4.432

6.  Centrally mediated bradycardia and hypotension induced by narcotic analgesics: dextromoramide and fentanyl.

Authors:  M Laubie; H Schmitt; J Canellas; J Roquebert; P Demichel
Journal:  Eur J Pharmacol       Date:  1974-09       Impact factor: 4.432

7.  Respiratory and cardiovascular effects of met-enkephalin applied to the ventral surface of the brain stem.

Authors:  J Flórez; A Mediavilla
Journal:  Brain Res       Date:  1977-12-23       Impact factor: 3.252

8.  Effects of enkephalins on arterial blood pressure are reduced by propranolol.

Authors:  W Simon; K Schaz; U Ganten; G Stock; K H Schlör; D Ganten
Journal:  Clin Sci Mol Med Suppl       Date:  1978-12

9.  Central cardiovascular effects of morphinomimetic peptides in dogs.

Authors:  M Laubie; H Schmitt; M Vincent; G Remond
Journal:  Eur J Pharmacol       Date:  1977-11-01       Impact factor: 4.432

10.  Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla.

Authors:  S F Atweh; M J Kuhar
Journal:  Brain Res       Date:  1977-03-18       Impact factor: 3.252

View more
  6 in total

1.  Opioid and non-opioid central cardiovascular effects of ketamine.

Authors:  S Seth; D Mukherjee; A K Choudhary; J N Sinha; S Gurtu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-11       Impact factor: 3.000

2.  Proceedings of the British Pharmacological Society. 5th-7th January, 1983. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1983-03       Impact factor: 8.739

3.  Contribution of central μ-receptors to switching pulmonary C-fibers-mediated rapid shallow breathing into an apnea by fentanyl in anesthetized rats.

Authors:  Zhenxiong Zhang; Cancan Zhang; Jianguo Zhuang; Fadi Xu
Journal:  Brain Res       Date:  2012-06-30       Impact factor: 3.252

4.  Influence of chronic naloxone treatment on development of hypertension in the spontaneously hypertensive rat.

Authors:  R M Quock; L K Vaughn; F J Kouchich
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-01       Impact factor: 3.000

5.  Potentiation by naloxone of pressor reflexes.

Authors:  J L Montastruc; P Montastruc; F Morales-Olivas
Journal:  Br J Pharmacol       Date:  1981-09       Impact factor: 8.739

6.  Activation of opioid μ-receptors, but not δ- or κ-receptors, switches pulmonary C-fiber-mediated rapid shallow breathing into an apnea in anesthetized rats.

Authors:  Zhenxiong Zhang; Cancan Zhang; Moxi Zhou; Fadi Xu
Journal:  Respir Physiol Neurobiol       Date:  2012-07-11       Impact factor: 1.931

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.